Scholarly publications and presentations by Rochester Regional Health's Internal Medicine department authors.

Follow


Submissions from 2026

Link

10-1-2026          Empiric and Trigger-Guided Superior Vena Cava Isolation in AF Ablation: Systematic Review and Meta-Analysis, Ojasav Sehrawat, Vasudha Garg, Rochester Regional Health, Cher Ying Foo, Rochester Regional Health, et al.

10-1-2026          Factor V Deficiency and Mechanical Valve Replacement: Challenges in Perioperative Hemostasis and Anticoagulation, Daniel Idoate Domench, Rochester Regional Health, Robin M. Reid, Rochester Regional Health, Dua Azim, Rochester Regional Health, et al.

Link

10-1-2026          Gut Microbiome-Modulating therapeutics and lipid profile in metabolic syndrome: A systematic review and meta-analysis of clinical trials, Pradipta Paul, Rochester Regional Health, Ridhima Kaul, Muhammad Ayyan, et al.

Link

10-1-2026          Heart Failure Devices: Treatment Options, Underutilization, and a Proposed Trigger System for Patient Referral and Evaluation, Marat Fudim, Dmitry M. Yaranov, Richa Gupta, et al.

Link

10-1-2026          Influenza as a Less Commonly Recognized Cause of Hemophagocytic Lymphohistiocytosis: A Systematic Review of Case Reports and Case Series, Kavya Balusu, Rochester Regional Health, Ali Abdelhay, Fnu Payal, Rochester Regional Health, et al.

Link

10-1-2026          S3294 Clinical Characteristics and Outcome of Gastrointestinal Immune-Related Adverse Events in Patients Receiving Immune Checkpoint Inhibitors: A Single-Center Cohort Study, John Shrestha, Rochester Regional Health, Kefang Sun, Rochester Regional Health, Apurva Shrestha, Rochester Regional Health, et al.

Link

9-15-2026          Demographics and clinical implications of a global bibliographic profile for the hypertrophic cardiomyopathy literature over 66 years (1960-2025), Ahmed Sayed, Rochester Regional Health, Ethan J. Rowin, Martin S. Maron, et al.

Link

9-1-2026          Cerebral embolic protection devices for transcatheter aortic valve replacement: A meta-analysis and trial sequential analysis, Hossam Elbenawi, Ibrahim Hassan, Mahmoud Shaaban Abdelgalil, et al.

Link

9-1-2026          Comparing the diagnostic performance of 19-gauge and 22-gauge needles in endoscopic ultrasound-guided liver biopsy: a systematic review and meta-analysis, Muhammad Ali Butt, Rahul Karna, Sheza Malik, Rochester Regional Health, et al.

Link

9-1-2026          Concurrent Sigmoid Microperforation in the Setting of Respiratory Syncytial Virus Infection in an Adult Patient: A Case Report, Brian P. Ireland, Valerie T. Bakly, Stephen Howard, Rochester Regional Health, et al.

Link

9-1-2026          Disseminated Coccidioidomycosis in an Immunocompetent Host: A Geographically and Rapidly Expanding Public Health Concern, Mansi Sharma, Lori Segletes, Abhay Sharma, et al.

Link

9-1-2026          Hydrocortisone Use for Septic Shock in Patients With CKD, Parth Dhamelia, Hashane Abeyagunawardene, Rajshekhar A. Kore, et al.

Link

9-1-2026          Prevalence of Coronary Microvascular Dysfunction Among US Adults: A Transportability Analysis, Ibrahim H. Hassan, Ahmed Sayed, Rochester Regional Health, Maria Alwan, et al.

Link

9-1-2026          Prognosis of Patients with Lung Cancer Admitted to the Intensive Care Unit: A Systematic Review and Meta-Analysis, Ahmed Elkhapery, Rochester Regional Health, Hazem Taifour, Rochester Regional Health, Chengu Niu, Rochester Regional Health, et al.

Link

8-1-2026          ABCL-1011: Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.

Link

8-1-2026          ABCL-1011: Comparative Real-World Efficacy and Safety of 4-1BB–Based (Liso-Cel/Tisa-Cel) vs CD28 Construct–Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, Muhammad Zain Raza, et al.

Link

8-1-2026          ABCL-669: Reversible Locked-in–Like Syndrome From Ifosfamide Encephalopathy in Relapsed T-Cell/Histiocyte-Rich Large B-Cell Lymphoma, Mutasim Idriss, Rochester Regional Health, ELrazi Ali, Mohamed Hegazi, et al.

Link

8-1-2026          ABCL-981: Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis, Muhammad Zain Raza, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, et al.

Link

8-1-2026          ABCL-981: Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis, Muhammad Zain Raza, Hafiz Muhammad Ehsan Arshad, Maryam Maqsood, Rochester Regional Health, et al.

8-1-2026          Acute Interstitial Nephritis after Single Dose of Ketorolac, Ishan Jani, Rochester Regional Health; Arjun Sekar, Rochester Regional Health; and Sergey Brodsky

Link

8-1-2026          ALL-1229: Clinical Impact of Tumor Lysis Syndrome in Acute Leukemia: A Comparative Analysis of Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia, Jawad Ahmed, Farheen Malik, Osama Mohiuddin, et al.

Link

8-1-2026          AML-1359: Global, Regional, and National Macroeconomic Burden of Acute Myeloid Leukemia: A Value-of-Lost-Welfare Analysis of 184 Countries, 2023, Yojan Chandra Reddy Vennapusa, Deep Sanjaykumar Sangani, Rutvij Bharatsinh Solanki, et al.

Link

8-1-2026          AML-1700: Leukemia Mortality Among Patients With Substance Use Disorder in the United States, 1999–2020: A Population-Based Analysis of Trends and Disparities, Parth Desai, Rutvij Bharatsinh Solanki, Deep Sanjaykumar Sangani, et al.

Link

8-1-2026          AML-1733: Trends in Acute Myeloid Leukemia Mortality Among Female Patients in the United States, 1999–2020: A Population-Based Analysis of Average Annual Percent Change, Krishna Sajeev, Rochester Regional Health, Sai Varun Gadde, FNU Bhuvan, et al.

Link

8-1-2026          AML-1737: Pneumonia as a Contributing Cause of Death in Acute Myeloid Leukemia Patients: A 22-Year Population-Based Analysis of Trends in the United States, 1999–2020, Rutvij Solanki, Parth Desai, Yojan Chandra Reddy Vennapusa, et al.